These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 14764461)
1. Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo. Pennati M; Binda M; De Cesare M; Pratesi G; Folini M; Citti L; Daidone MG; Zunino F; Zaffaroni N Carcinogenesis; 2004 Jul; 25(7):1129-36. PubMed ID: 14764461 [TBL] [Abstract][Full Text] [Related]
2. Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression. Pennati M; Binda M; Colella G; Folini M; Citti L; Villa R; Daidone MG; Zaffaroni N J Invest Dermatol; 2003 Apr; 120(4):648-54. PubMed ID: 12648230 [TBL] [Abstract][Full Text] [Related]
3. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells. Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment. Li H; Niederkorn JY; Neelam S; Alizadeh H Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731 [TBL] [Abstract][Full Text] [Related]
5. Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavage. Tomicic MT; Christmann M; Kaina B J Pharmacol Exp Ther; 2010 Jan; 332(1):316-25. PubMed ID: 19812371 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo. Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318 [TBL] [Abstract][Full Text] [Related]
7. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis. Wang Z; Sampath J; Fukuda S; Pelus LM Cancer Res; 2005 Sep; 65(18):8224-32. PubMed ID: 16166298 [TBL] [Abstract][Full Text] [Related]
9. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823 [TBL] [Abstract][Full Text] [Related]
10. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo]. Ji YB; Zhou JH; Zuo MX; You QD Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773 [TBL] [Abstract][Full Text] [Related]
11. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death. Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302 [TBL] [Abstract][Full Text] [Related]
12. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice. Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125 [TBL] [Abstract][Full Text] [Related]
13. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels. Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385 [TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of survivin-specific small interfering RNA and topotecan in renal cancer cells: topotecan enhances liposome-mediated transfection by increasing cellular uptake. Sato A; Ito K; Asano T; Sumitomo M; Asano T; Hayakawa M Int J Oncol; 2007 Mar; 30(3):695-700. PubMed ID: 17273771 [TBL] [Abstract][Full Text] [Related]
15. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707 [TBL] [Abstract][Full Text] [Related]
16. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Rödel F; Hoffmann J; Distel L; Herrmann M; Noisternig T; Papadopoulos T; Sauer R; Rödel C Cancer Res; 2005 Jun; 65(11):4881-7. PubMed ID: 15930309 [TBL] [Abstract][Full Text] [Related]
17. Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells. Choi KS; Lee TH; Jung MH Cancer Gene Ther; 2003 Feb; 10(2):87-95. PubMed ID: 12536196 [TBL] [Abstract][Full Text] [Related]
18. Topotecan and small interfering RNA suppress survivin expression synergistically in Caki-1 renal cancer cells: Direct suppression of survivin and enhancement of transfection efficiency by topotecan. Sato A; Ito K; Asano T; Sumitomo M; Asano T; Hayakawa M Int J Oncol; 2008 Jan; 32(1):171-6. PubMed ID: 18097556 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells. Hideshima T; Catley L; Raje N; Chauhan D; Podar K; Mitsiades C; Tai YT; Vallet S; Kiziltepe T; Ocio E; Ikeda H; Okawa Y; Hideshima H; Munshi NC; Yasui H; Richardson PG; Anderson KC Br J Haematol; 2007 Sep; 138(6):783-91. PubMed ID: 17760810 [TBL] [Abstract][Full Text] [Related]
20. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin. Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]